HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ASCLETIS-B

5.260

-1.240-19.08%

Volume:6.13M

Turnover:32.55M

Market Cap:5.06B

PE:-16.51

High:5.880

Open:5.880

Low:5.000

Close:6.500

Loading ...

Overview Company News Filings

Ascletis Pharma Reports Positive Interim Results for Obesity Treatment; Shares Up 6%

MT Newswires Live

BRIEF-Ascletis Announces Positive Interim Results from Its U.S. Phase Ib Trial with ASC30, a Potentially First-in-Class Subcutaneous Injection Small Molecule GLP-1R Agonist

Ascletis Announces Positive Interim Results From Its U.S. Phase Ib Trial With Asc30, a Potentially First-in-Class Subcutaneous Injection Small Molecule Glp-1R Agonist

THOMSON REUTERS

Ascletis Pharma Inc - Asc30 Sq Injection Shows 36-Day Half-Life in Obesity Patients

THOMSON REUTERS

Ascletis Pharma: Announces Positive Interim Results From Its U.S. Phase Ib Trial With Asc30

THOMSON REUTERS

Ascletis Pharma's Attributable Loss Widens in 2024 as Revenue Plummets

MT Newswires Live

Ascletis Pharma FY Revenue RMB 1.3 Million

THOMSON REUTERS

BUZZ-China's Ascletis hits 6-year peak on good results for weight loss drug

Ascletis' Anti-Obesity Drug Found Safe in Australia Phase 1B Trial; Shares Rise 6%

MT Newswires Live

BRIEF-Ascletis Pharma Announces Positive Phase Ib Results And FDA Clearance

Ascletis Pharma Inc - Announces Positive Phase Ib Results and FDA Clearance

THOMSON REUTERS

Ascletis Pharma Inc - No Clinically Significant Changes in Liver Enzymes Observed

THOMSON REUTERS

Ascletis Announces Positive Interim Results From First Two Cohorts of U.S. Phase Ib Multiple Ascending Dose Study of Small Molecule Oral Glp-1R Agonist Asc30

THOMSON REUTERS

Ascletis Pharma Inc - Cohort 3 Expected to Be Completed by End of March 2025

THOMSON REUTERS

Ascletis Pharma Inc - Asc30 Well Tolerated With No Serious Adverse Events in Mad Cohorts 1 and 2

THOMSON REUTERS

Ascletis Pharma Sees Positive Results from Obesity Drug Study

MT Newswires Live

Ascletis Pharma Inc - Asc30 Shows Dose-Proportional Pk Properties and Long Half-Life up to 60 Hours

THOMSON REUTERS

Ascletis Announces Positive Results From U.S. Phase Ia Single Ascending Dose Study of Small Molecule Oral Glp-1R Agonist Asc30 and Provides Program Update

THOMSON REUTERS

Ascletis Pharma Inc: Topline Results From U.S. Phase Ib Multiple Ascending Dose Study of Asc30 Oral Tablet, Expected by End of March 2025

THOMSON REUTERS

Ascletis Pharma Inc - Asc30 Generally Safe and Well Tolerated in Phase Ia Study

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/01672/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01672","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01672\",,,,,undefined,":{"symbol":"01672","market":"HK","secType":"STK","nameCN":"ASCLETIS-B","latestPrice":5.26,"timestamp":1743993609227,"preClose":6.5,"halted":0,"volume":6126200,"delay":0,"floatShares":961999999,"shares":961999999,"eps":-0.31851774288089635,"marketStatus":"Trading","change":-1.24,"latestTime":"04-07 10:40:10","open":5.88,"high":5.88,"low":5,"amount":32552401,"amplitude":0.135385,"askPrice":5.28,"askSize":7000,"bidPrice":5.26,"bidSize":5000,"shortable":0,"etf":0,"ttmEps":-0.31851774288089635,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1743998400000},"marketStatusCode":2,"adr":0,"listingDate":1533052800000,"exchange":"SEHK","adjPreClose":6.5,"openAndCloseTimeList":[[1743989400000,1743998400000],[1744002000000,1744012800000]],"volumeRatio":3.400985,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01672\",,,,,undefined,":{"symbol":"01672","floatShares":961999999,"roa":"-10.96%","roe":"-13.97%","lyrEps":-0.318518,"volumeRatio":3.400985,"shares":961999999,"dividePrice":0,"high":5.88,"amplitude":0.135385,"preClose":6.5,"low":5,"week52Low":0.76,"pbRate":"2.43","psRate":"3720.35","week52High":9.28,"institutionHeld":0,"latestPrice":5.26,"committee":-0.166667,"eps":-0.31851774288089635,"divideRate":0,"volume":6126200,"delay":0,"ttmEps":-0.31851774288089635,"open":5.88,"prevYearClose":3.01,"prevWeekClose":6.5,"prevMonthClose":8.08,"prevQuarterClose":8.08,"fiveDayClose":7.45,"twentyDayClose":6.9,"sixtyDayClose":3.35},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01672\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2524915612","title":"Ascletis Pharma Reports Positive Interim Results for Obesity Treatment; Shares Up 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2524915612","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524915612?lang=en_us&edition=fundamental","pubTime":"2025-04-01 15:10","pubTimestamp":1743491410,"startTime":"0","endTime":"0","summary":"Ascletis Pharma  posted promising Phase Ib trial results in the U.S. for ASC30, a potential first-in-class GLP-1 receptor agonist for treating obesity, according to a Monday filing with the Hong Kong bourse.A single subcutaneous injection of ASC30 showed a 36-day half-life, supporting once-monthly dosing. The oral tablet form of ASC30 also demonstrated \"6.3% weight loss in patients with obesity after a four-week treatment.\"Ascletis holds global patent protection until 2044 for ASC30.The pharmaceutical shares were up by 5.8%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1574","BK1515","BK1161","01672"],"gpt_icon":0},{"id":"2523491203","title":"BRIEF-Ascletis Announces Positive Interim Results from Its U.S. Phase Ib Trial with ASC30, a Potentially First-in-Class Subcutaneous Injection Small Molecule GLP-1R Agonist","url":"https://stock-news.laohu8.com/highlight/detail?id=2523491203","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523491203?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:02","pubTimestamp":1743418956,"startTime":"0","endTime":"0","summary":"BRIEF-Ascletis Announces Positive Interim Results from Its U.S. Phase Ib Trial with ASC30, a Potentially First-in-Class Subcutaneous Injection Small Molecule GLP-1R AgonistMarch 31 (Reuters) - Ascleti","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nTUA4T6HRZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01672","BK1574","BK1515"],"gpt_icon":0},{"id":"2523912791","title":"Ascletis Announces Positive Interim Results From Its U.S. Phase Ib Trial With Asc30, a Potentially First-in-Class Subcutaneous Injection Small Molecule Glp-1R Agonist","url":"https://stock-news.laohu8.com/highlight/detail?id=2523912791","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523912791?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:00","pubTimestamp":1743418807,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nTUA4T6HRZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1515","01672","BK1161"],"gpt_icon":0},{"id":"2523912730","title":"Ascletis Pharma Inc - Asc30 Sq Injection Shows 36-Day Half-Life in Obesity Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2523912730","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523912730?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:00","pubTimestamp":1743418807,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nTUA4T6HRZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1515","BK1161","01672"],"gpt_icon":0},{"id":"2523912676","title":"Ascletis Pharma:  Announces Positive Interim Results From Its U.S. Phase Ib Trial With Asc30","url":"https://stock-news.laohu8.com/highlight/detail?id=2523912676","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523912676?lang=en_us&edition=fundamental","pubTime":"2025-03-31 18:55","pubTimestamp":1743418510,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QE0UL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01672","BK1515","BK1161","BK1574"],"gpt_icon":0},{"id":"2522340330","title":"Ascletis Pharma's Attributable Loss Widens in 2024 as Revenue Plummets","url":"https://stock-news.laohu8.com/highlight/detail?id=2522340330","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522340330?lang=en_us&edition=fundamental","pubTime":"2025-03-27 17:18","pubTimestamp":1743067093,"startTime":"0","endTime":"0","summary":"Ascletis Pharma's  attributed losses in 2024 widened year on year to 300.9 million yuan or 0.3005 yuan per share from 144.7 million yuan or 0.1347 yuan per share, according to a Hong Kong Stock Exchange disclosure on Wednesday.The biotechnology company's revenue plummeted to 1.3 million yuan from 56.6 million yuan a year earlier.The company's shares closed 10% lower.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01672"],"gpt_icon":0},{"id":"2522294822","title":"Ascletis Pharma FY Revenue RMB 1.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2522294822","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522294822?lang=en_us&edition=fundamental","pubTime":"2025-03-26 18:40","pubTimestamp":1742985625,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nPLX93D77F:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1515","01672","BK1161"],"gpt_icon":0},{"id":"2518103704","title":"BUZZ-China's Ascletis hits 6-year peak on good results for weight loss drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2518103704","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518103704?lang=en_us&edition=fundamental","pubTime":"2025-03-12 14:31","pubTimestamp":1741761077,"startTime":"0","endTime":"0","summary":"BUZZ-China's Ascletis hits 6-year peak on good results for weight loss drug** Shares of Chinese pharmaceutical products developer Ascletis Pharma Inc 1672.HK jump 8.7% to HK$7.99, their highest since March 2019** Stock on course for the biggest one-day gain since March 3; on track for third straight session of rise** Ascletis announces positive topline results of Phase 1B studies of weight loss drug candidate ASC47 monotherapy in Australia ** Says U.S. Food and Drug Administration has cleared the U.S. Investigational New Drug application for ASC47 in combination with semaglutide for the treatment of obesity** Hong Kong's healthcare index .HSCIH and Hang Seng Index .HSI both slip 0.1%** Stock up 144.2% YTD    ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250312:nL1N3PV061:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","BK1515","BK1161","BK1574"],"gpt_icon":0},{"id":"2518903555","title":"Ascletis' Anti-Obesity Drug Found Safe in Australia Phase 1B Trial; Shares Rise 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518903555","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518903555?lang=en_us&edition=fundamental","pubTime":"2025-03-12 12:26","pubTimestamp":1741753597,"startTime":"0","endTime":"0","summary":"Ascletis Pharma  showed positive topline results in its phase 1B trial for its ASC47 anti-obesity drug in Australia, according to a Wednesday filing with the Hong Kong bourse.The trial found ASC47 safe and well-tolerated in patients with low-density lipoprotein cholesterol and obesity, the filing said.Meanwhile, the US Food and Drug Administration also cleared ASC47's combination with semaglutide for obesity, the filing said.Shares rose 6% during Wednesday's late morning trading.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","01672","XAO.AU","BK1574","BK1515","XKO.AU","XJO.AU"],"gpt_icon":0},{"id":"2518408892","title":"BRIEF-Ascletis Pharma Announces Positive Phase Ib Results And FDA Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2518408892","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518408892?lang=en_us&edition=fundamental","pubTime":"2025-03-12 09:13","pubTimestamp":1741742024,"startTime":"0","endTime":"0","summary":"BRIEF-Ascletis Pharma Announces Positive Phase Ib Results And FDA ClearanceMarch 12 (Reuters) - Ascletis Pharma Inc 1672.HK:ANNOUNCES POSITIVE PHASE IB RESULTS AND FDA CLEARANCEFurther company coverage: 1672.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250312:nFWN3PU14R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1515","BK1161","01672"],"gpt_icon":0},{"id":"2518709399","title":"Ascletis Pharma Inc - Announces Positive Phase Ib Results and FDA Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2518709399","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518709399?lang=en_us&edition=fundamental","pubTime":"2025-03-12 07:16","pubTimestamp":1741735017,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nFWN3PU14R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1515","BK1161","01672"],"gpt_icon":0},{"id":"2512918105","title":"Ascletis Pharma Inc - No Clinically Significant Changes in Liver Enzymes Observed","url":"https://stock-news.laohu8.com/highlight/detail?id=2512918105","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512918105?lang=en_us&edition=fundamental","pubTime":"2025-02-19 20:00","pubTimestamp":1739966403,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250219:nTUA9BH2YR:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","BK1515","01672","BK1574"],"gpt_icon":0},{"id":"2512105957","title":"Ascletis Announces Positive Interim Results From First Two Cohorts of U.S. Phase Ib Multiple Ascending Dose Study of Small Molecule Oral Glp-1R Agonist Asc30","url":"https://stock-news.laohu8.com/highlight/detail?id=2512105957","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512105957?lang=en_us&edition=fundamental","pubTime":"2025-02-19 20:00","pubTimestamp":1739966403,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250219:nTUA9BH2YR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01672","BK1161","BK1574","BK1515"],"gpt_icon":0},{"id":"2512105604","title":"Ascletis Pharma Inc - Cohort 3 Expected to Be Completed by End of March 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2512105604","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512105604?lang=en_us&edition=fundamental","pubTime":"2025-02-19 20:00","pubTimestamp":1739966403,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250219:nTUA9BH2YR:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01672","BK1515","BK1161","BK1574"],"gpt_icon":0},{"id":"2512059861","title":"Ascletis Pharma Inc - Asc30 Well Tolerated With No Serious Adverse Events in Mad Cohorts 1 and 2","url":"https://stock-news.laohu8.com/highlight/detail?id=2512059861","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512059861?lang=en_us&edition=fundamental","pubTime":"2025-02-19 20:00","pubTimestamp":1739966403,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250219:nTUA9BH2YR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1515","01672","BK1161"],"gpt_icon":0},{"id":"2505714021","title":"Ascletis Pharma Sees Positive Results from Obesity Drug Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2505714021","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505714021?lang=en_us&edition=fundamental","pubTime":"2025-01-22 18:41","pubTimestamp":1737542496,"startTime":"0","endTime":"0","summary":"Ascletis Pharma (HKG:1672) said Wednesday it has observed positive topline results from its U.S. single ascending dose study of ASC30 oral tablet in patients with obesity, a same-day bourse filing said.The ASC30 oral tablet was generally safe and well tolerated in the Phase Ia study.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1515","01672","BK1161","BK1574"],"gpt_icon":0},{"id":"2505881228","title":"Ascletis Pharma Inc - Asc30 Shows Dose-Proportional Pk Properties and Long Half-Life up to 60 Hours","url":"https://stock-news.laohu8.com/highlight/detail?id=2505881228","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505881228?lang=en_us&edition=fundamental","pubTime":"2025-01-21 19:00","pubTimestamp":1737457213,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250121:nTUAP06MK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","BK1161","BK1574","01672"],"gpt_icon":0},{"id":"2505839228","title":"Ascletis Announces Positive Results From U.S. Phase Ia Single Ascending Dose Study of Small Molecule Oral Glp-1R Agonist Asc30 and Provides Program Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2505839228","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505839228?lang=en_us&edition=fundamental","pubTime":"2025-01-21 19:00","pubTimestamp":1737457213,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250121:nTUAP06MK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","01672","BK1574","BK1515"],"gpt_icon":0},{"id":"2505288532","title":"Ascletis Pharma Inc:  Topline Results From U.S. Phase Ib Multiple Ascending Dose  Study of Asc30 Oral Tablet, Expected by End of March 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2505288532","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505288532?lang=en_us&edition=fundamental","pubTime":"2025-01-21 19:00","pubTimestamp":1737457213,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250121:nTUAP06MK:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","01672","BK1574","BK1161"],"gpt_icon":0},{"id":"2505288372","title":"Ascletis Pharma Inc - Asc30 Generally Safe and Well Tolerated in Phase Ia Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2505288372","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505288372?lang=en_us&edition=fundamental","pubTime":"2025-01-21 19:00","pubTimestamp":1737457213,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250121:nTUAP06MK:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1515","01672","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":31}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01672\",params:#limit:5,,,undefined,":[{"date":"2025-03-26","symbol":"01672","type":"earning","reportTimeType":"pre","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742952600000,"name":null,"time":"Pre-Market","dateTimestamp":1742918400000,"actualEps":null},{"date":"2024-08-30","symbol":"01672","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724981400000,"name":null,"time":"","dateTimestamp":1724947200000,"actualEps":null},{"date":"2024-03-25","symbol":"01672","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null},{"date":"2023-08-21","symbol":"01672","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692581400000,"name":null,"time":"","dateTimestamp":1692547200000,"actualEps":null},{"date":"2023-03-20","symbol":"01672","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1679275800000,"name":null,"time":"","dateTimestamp":1679241600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01672\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01672\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.3333,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":3,"updateTime":1740067200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01672\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01672","date":"2025-04-03","current":-19.455031,"percent":0.281072,"low":-38.119394,"twenty":-25.920491,"median":-13.637196,"eighty":-7.037853,"high":-3.060869,"avg":-15.317992,"sd":8.760764,"marketCap":6253500500},"quantilePoints":[{"date":"2020-04-09","current":-29.635591,"twenty":-44.835189,"median":-34.737356,"eighty":-31.968158,"marketCap":3130930880},{"date":"2020-04-17","current":-30.405048,"twenty":-44.497514,"median":-34.028655,"eighty":-31.243283,"marketCap":3197311040},{"date":"2020-04-24","current":-29.386804,"twenty":-44.237054,"median":-33.44722,"eighty":-30.614603,"marketCap":3086677440},{"date":"2020-04-29","current":-29.366327,"twenty":-43.998108,"median":-33.316641,"eighty":-30.488632,"marketCap":3086677440},{"date":"2020-05-08","current":-28.720011,"twenty":-43.742763,"median":-33.216922,"eighty":-29.920164,"marketCap":3020297280},{"date":"2020-05-15","current":-30.523864,"twenty":-43.676787,"median":-33.155055,"eighty":-29.787999,"marketCap":3197311040},{"date":"2020-05-22","current":-32.317626,"twenty":-43.671474,"median":-33.146568,"eighty":-29.841157,"marketCap":3374324800},{"date":"2020-05-29","current":-30.352513,"twenty":-43.609525,"median":-32.861468,"eighty":-29.887813,"marketCap":3164120960},{"date":"2020-06-05","current":-31.29174,"twenty":-43.41253,"median":-32.731433,"eighty":-29.920164,"marketCap":3285817920},{"date":"2020-06-12","current":-30.767864,"twenty":-43.291596,"median":-32.553809,"eighty":-30.0065,"marketCap":3230501120},{"date":"2020-06-19","current":-35.339691,"twenty":-42.89026,"median":-32.558287,"eighty":-30.065708,"marketCap":3717288960},{"date":"2020-06-26","current":-34.213716,"twenty":-42.513122,"median":-32.589785,"eighty":-30.107313,"marketCap":3595592000},{"date":"2020-07-03","current":-33.740627,"twenty":-42.327708,"median":-32.765713,"eighty":-30.166665,"marketCap":3551338560},{"date":"2020-07-10","current":-33.734264,"twenty":-42.166427,"median":-32.993269,"eighty":-30.217826,"marketCap":3584528640},{"date":"2020-07-17","current":-33.992609,"twenty":-41.541778,"median":-33.146568,"eighty":-30.36302,"marketCap":3617718720},{"date":"2020-07-24","current":-32.456398,"twenty":-40.904541,"median":-33.172562,"eighty":-30.428811,"marketCap":3440704960},{"date":"2020-07-31","current":-34.757048,"twenty":-40.41079,"median":-33.163542,"eighty":-30.527962,"marketCap":3706225600},{"date":"2020-08-07","current":-32.750421,"twenty":-39.04885,"median":-33.199252,"eighty":-30.557099,"marketCap":3496021760},{"date":"2020-08-14","current":-31.01438,"twenty":-38.045276,"median":-33.146568,"eighty":-30.60938,"marketCap":3319008000},{"date":"2020-08-21","current":-32.726757,"twenty":-37.643525,"median":-33.03201,"eighty":-30.640632,"marketCap":3518148480},{"date":"2020-08-28","current":-29.92781,"twenty":-37.215218,"median":-32.842038,"eighty":-30.637123,"marketCap":3385388160},{"date":"2020-09-04","current":-26.610153,"twenty":-37.175148,"median":-32.758067,"eighty":-30.428811,"marketCap":3020297280},{"date":"2020-09-11","current":-27.165883,"twenty":-37.063041,"median":-32.726757,"eighty":-30.088987,"marketCap":3086677440},{"date":"2020-09-18","current":-27.869385,"twenty":-36.720327,"median":-32.577286,"eighty":-29.911296,"marketCap":3197311040},{"date":"2020-09-25","current":-26.537276,"twenty":-36.379853,"median":-32.549331,"eighty":-29.68082,"marketCap":3020297280},{"date":"2020-09-30","current":-26.895021,"twenty":-36.257308,"median":-32.450755,"eighty":-29.495304,"marketCap":3075614080},{"date":"2020-10-09","current":-27.562384,"twenty":-36.10597,"median":-32.357389,"eighty":-29.321809,"marketCap":3197311040},{"date":"2020-10-16","current":-29.275632,"twenty":-35.984854,"median":-32.259237,"eighty":-29.068393,"marketCap":3394658960},{"date":"2020-10-23","current":-29.488253,"twenty":-35.957754,"median":-32.073854,"eighty":-28.955111,"marketCap":3424613820},{"date":"2020-10-30","current":-26.437999,"twenty":-35.956418,"median":-32.003605,"eighty":-28.82979,"marketCap":3070846980},{"date":"2020-11-06","current":-26.60077,"twenty":-35.586274,"median":-31.898341,"eighty":-28.698509,"marketCap":3125880080},{"date":"2020-11-13","current":-26.110515,"twenty":-35.299289,"median":-31.691741,"eighty":-28.344195,"marketCap":3070846980},{"date":"2020-11-20","current":-26.400807,"twenty":-35.227708,"median":-31.598047,"eighty":-28.200646,"marketCap":3124460080},{"date":"2020-11-27","current":-25.996763,"twenty":-35.145931,"median":-31.506654,"eighty":-28.026747,"marketCap":3069451980},{"date":"2020-12-04","current":-26.063446,"twenty":-34.979619,"median":-31.354566,"eighty":-27.911719,"marketCap":3099467640},{"date":"2020-12-11","current":-26.31125,"twenty":-34.827046,"median":-31.274607,"eighty":-27.56687,"marketCap":3121449680},{"date":"2020-12-18","current":-27.740507,"twenty":-34.767763,"median":-31.233891,"eighty":-27.429855,"marketCap":3296346000},{"date":"2020-12-24","current":-26.603446,"twenty":-34.711392,"median":-31.107005,"eighty":-27.316987,"marketCap":3164492160},{"date":"2020-12-31","current":-26.500215,"twenty":-34.587018,"median":-31.004106,"eighty":-27.169357,"marketCap":3153504340},{"date":"2021-01-08","current":-25.623114,"twenty":-26.33735,"median":-26.070062,"eighty":-25.606579,"marketCap":3076589600},{"date":"2021-01-15","current":-26.301013,"twenty":-26.257669,"median":-26.058174,"eighty":-25.606579,"marketCap":3153504340},{"date":"2021-01-22","current":-27.687281,"twenty":-26.817021,"median":-26.133868,"eighty":-25.701626,"marketCap":3318321640},{"date":"2021-01-29","current":-25.459845,"twenty":-26.817021,"median":-26.18132,"eighty":-25.701626,"marketCap":3076589600},{"date":"2021-02-05","current":-26.710974,"twenty":-27.144116,"median":-26.500215,"eighty":-25.780011,"marketCap":3208443440},{"date":"2021-02-11","current":-26.94677,"twenty":-27.163157,"median":-26.50182,"eighty":-25.840901,"marketCap":3241406900},{"date":"2021-02-19","current":-29.217648,"twenty":-27.39605,"median":-26.606395,"eighty":-25.934212,"marketCap":3516102400},{"date":"2021-02-26","current":-27.726401,"twenty":-28.252216,"median":-26.780324,"eighty":-26.051041,"marketCap":3329309460},{"date":"2021-03-05","current":-26.695247,"twenty":-28.196164,"median":-26.801757,"eighty":-26.075007,"marketCap":3197455620},{"date":"2021-03-12","current":-27.661035,"twenty":-27.925684,"median":-26.796554,"eighty":-25.934212,"marketCap":3307333820},{"date":"2021-03-19","current":-27.578315,"twenty":-28.013713,"median":-26.946171,"eighty":-26.051041,"marketCap":3296346000},{"date":"2021-03-26","current":-26.684915,"twenty":-27.992927,"median":-26.925194,"eighty":-26.075007,"marketCap":3175479980},{"date":"2021-04-01","current":-12.856888,"twenty":-27.937324,"median":-26.841361,"eighty":-25.906193,"marketCap":3186467800},{"date":"2021-04-09","current":-12.651626,"twenty":-27.902405,"median":-26.79135,"eighty":-25.749374,"marketCap":3142516520},{"date":"2021-04-16","current":-12.515766,"twenty":-27.83964,"median":-26.703111,"eighty":-25.606579,"marketCap":3120540880},{"date":"2021-04-23","current":-12.748275,"twenty":-27.761167,"median":-26.610487,"eighty":-20.3699,"marketCap":3186467800},{"date":"2021-04-30","current":-12.958615,"twenty":-27.702929,"median":-26.546385,"eighty":-12.849963,"marketCap":3252394720},{"date":"2021-05-07","current":-13.875629,"twenty":-27.671533,"median":-26.500215,"eighty":-12.917924,"marketCap":3505114580},{"date":"2021-05-14","current":-13.623513,"twenty":-27.632266,"median":-26.264893,"eighty":-13.033167,"marketCap":3439187660},{"date":"2021-05-21","current":-13.663274,"twenty":-27.599178,"median":-26.114327,"eighty":-13.140261,"marketCap":3450175480},{"date":"2021-05-28","current":-15.770587,"twenty":-27.536493,"median":-26.046286,"eighty":-13.276483,"marketCap":4021542120},{"date":"2021-06-04","current":-14.720056,"twenty":-27.44752,"median":-25.775671,"eighty":-13.355805,"marketCap":3735858800},{"date":"2021-06-11","current":-16.063352,"twenty":-27.383939,"median":-25.742295,"eighty":-13.363408,"marketCap":4076481220},{"date":"2021-06-18","current":-14.31767,"twenty":-27.321052,"median":-25.623114,"eighty":-13.37885,"marketCap":3604004960},{"date":"2021-06-25","current":-15.287624,"twenty":-27.213321,"median":-25.50862,"eighty":-13.470373,"marketCap":3845737000},{"date":"2021-07-02","current":-15.35814,"twenty":-27.20728,"median":-21.095972,"eighty":-13.623513,"marketCap":3856724820},{"date":"2021-07-09","current":-15.855335,"twenty":-27.138398,"median":-16.377335,"eighty":-13.663274,"marketCap":3977590840},{"date":"2021-07-16","current":-14.892058,"twenty":-27.096973,"median":-16.253526,"eighty":-13.686225,"marketCap":3735858800},{"date":"2021-07-23","current":-14.192621,"twenty":-26.97726,"median":-16.035624,"eighty":-13.755247,"marketCap":3560053680},{"date":"2021-07-30","current":-12.791706,"twenty":-26.94677,"median":-15.809995,"eighty":-13.432088,"marketCap":3219431260},{"date":"2021-08-06","current":-12.341273,"twenty":-26.946171,"median":-15.662682,"eighty":-13.226349,"marketCap":3098565240},{"date":"2021-08-13","current":-12.368185,"twenty":-26.904217,"median":-15.576148,"eighty":-12.99939,"marketCap":3109553060},{"date":"2021-08-20","current":-11.921226,"twenty":-26.880965,"median":-15.419458,"eighty":-12.856888,"marketCap":2988687040},{"date":"2021-08-27","current":-9.483763,"twenty":-26.801757,"median":-15.385644,"eighty":-12.791706,"marketCap":3065601780},{"date":"2021-09-03","current":-9.989583,"twenty":-26.79135,"median":-15.321348,"eighty":-12.740344,"marketCap":3230419080},{"date":"2021-09-10","current":-10.099521,"twenty":-26.758891,"median":-15.242013,"eighty":-12.683051,"marketCap":3274370360},{"date":"2021-09-17","current":-9.347674,"twenty":-26.710974,"median":-15.066642,"eighty":-12.561454,"marketCap":3021650500},{"date":"2021-09-24","current":-9.343351,"twenty":-26.698392,"median":-15.042421,"eighty":-12.475139,"marketCap":3021650500},{"date":"2021-09-30","current":-8.973563,"twenty":-26.689048,"median":-14.919568,"eighty":-12.420739,"marketCap":2911772300},{"date":"2021-10-08","current":-9.244464,"twenty":-26.640258,"median":-14.827353,"eighty":-12.337134,"marketCap":2999538360},{"date":"2021-10-15","current":-9.166534,"twenty":-26.60885,"median":-14.642735,"eighty":-12.284716,"marketCap":2976292730},{"date":"2021-10-22","current":-9.46655,"twenty":-26.590594,"median":-14.417378,"eighty":-12.067263,"marketCap":3095773440},{"date":"2021-10-29","current":-9.149748,"twenty":-26.550486,"median":-14.330599,"eighty":-10.167628,"marketCap":2984772960},{"date":"2021-11-05","current":-8.624888,"twenty":-26.516254,"median":-14.241832,"eighty":-9.980119,"marketCap":2818192610},{"date":"2021-11-12","current":-9.42017,"twenty":-26.501178,"median":-13.883402,"eighty":-9.642783,"marketCap":3090742560},{"date":"2021-11-19","current":-9.993809,"twenty":-26.445097,"median":-13.875629,"eighty":-9.639623,"marketCap":3274313120},{"date":"2021-11-26","current":-9.93865,"twenty":-26.337858,"median":-13.67475,"eighty":-9.647662,"marketCap":3257283040},{"date":"2021-12-03","current":-10.40565,"twenty":-26.272117,"median":-13.432088,"eighty":-9.665551,"marketCap":3416642270},{"date":"2021-12-10","current":-10.070825,"twenty":-26.190811,"median":-13.356835,"eighty":-9.665551,"marketCap":3312350560},{"date":"2021-12-17","current":-9.235444,"twenty":-26.118235,"median":-13.082869,"eighty":-9.631582,"marketCap":3035489310},{"date":"2021-12-24","current":-9.813413,"twenty":-26.084896,"median":-12.999709,"eighty":-9.575593,"marketCap":3228535530},{"date":"2021-12-31","current":-10.844012,"twenty":-26.065307,"median":-12.934788,"eighty":-9.578506,"marketCap":3575354860},{"date":"2022-01-07","current":-11.844839,"twenty":-13.746537,"median":-11.844839,"eighty":-10.061407,"marketCap":3890507720},{"date":"2022-01-14","current":-13.898995,"twenty":-13.746537,"median":-12.309572,"eighty":-10.552334,"marketCap":4575150140},{"date":"2022-01-21","current":-16.436478,"twenty":-16.916833,"median":-13.314768,"eighty":-11.444508,"marketCap":5422802660},{"date":"2022-01-28","current":-12.515763,"twenty":-15.891088,"median":-13.294428,"eighty":-11.905461,"marketCap":4118721860},{"date":"2022-02-04","current":-12.918373,"twenty":-15.527494,"median":-13.172133,"eighty":-11.945875,"marketCap":4249129940},{"date":"2022-02-11","current":-13.749623,"twenty":-15.527494,"median":-13.643555,"eighty":-12.107031,"marketCap":4531680780},{"date":"2022-02-18","current":-14.699583,"twenty":-15.230713,"median":-13.762166,"eighty":-12.512113,"marketCap":4868568320},{"date":"2022-02-25","current":-14.401585,"twenty":-15.230713,"median":-13.898995,"eighty":-12.515763,"marketCap":4781629600},{"date":"2022-03-04","current":-15.050437,"twenty":-15.15343,"median":-14.35444,"eighty":-12.745602,"marketCap":4998976400},{"date":"2022-03-11","current":-11.829182,"twenty":-15.076137,"median":-14.197144,"eighty":-12.515763,"marketCap":3923109740},{"date":"2022-03-18","current":-18.160245,"twenty":-15.15343,"median":-14.130354,"eighty":-12.512113,"marketCap":5998771680},{"date":"2022-03-25","current":-23.265801,"twenty":-15.804034,"median":-14.369858,"eighty":-12.515763,"marketCap":5694486160},{"date":"2022-04-01","current":-22.572946,"twenty":-18.160245,"median":-14.63199,"eighty":-12.7161,"marketCap":5531476060},{"date":"2022-04-08","current":-23.715707,"twenty":-21.833142,"median":-14.748151,"eighty":-12.739702,"marketCap":5814026900},{"date":"2022-04-14","current":-21.490504,"twenty":-21.683047,"median":-14.849995,"eighty":-12.849265,"marketCap":5259792560},{"date":"2022-04-22","current":-19.863698,"twenty":-21.600394,"median":-14.955439,"eighty":-12.933785,"marketCap":4770762260},{"date":"2022-04-29","current":-19.590787,"twenty":-21.409116,"median":-15.049314,"eighty":-13.002214,"marketCap":4629486840},{"date":"2022-05-06","current":-17.396263,"twenty":-21.270237,"median":-15.076137,"eighty":-13.110961,"marketCap":4076752500},{"date":"2022-05-13","current":-18.610663,"twenty":-21.20305,"median":-15.230713,"eighty":-13.274087,"marketCap":4283307960},{"date":"2022-05-20","current":-18.632644,"twenty":-20.958324,"median":-15.665764,"eighty":-13.314768,"marketCap":4348536000},{"date":"2022-05-27","current":-17.623136,"twenty":-20.880127,"median":-16.522446,"eighty":-13.630838,"marketCap":4109366520},{"date":"2022-06-02","current":-17.853668,"twenty":-20.492571,"median":-17.233543,"eighty":-13.641012,"marketCap":4185465900},{"date":"2022-06-10","current":-18.161257,"twenty":-19.970095,"median":-17.41371,"eighty":-13.669209,"marketCap":4228951260},{"date":"2022-06-17","current":-17.854023,"twenty":-19.645369,"median":-17.431157,"eighty":-13.717329,"marketCap":4152851880},{"date":"2022-06-24","current":-18.109092,"twenty":-19.371762,"median":-17.63025,"eighty":-13.745249,"marketCap":4228951260},{"date":"2022-06-30","current":-17.673991,"twenty":-19.310985,"median":-17.653236,"eighty":-13.764675,"marketCap":4120237860},{"date":"2022-07-08","current":-18.30801,"twenty":-19.310985,"median":-17.673991,"eighty":-13.849281,"marketCap":4272436620},{"date":"2022-07-15","current":-16.316301,"twenty":-19.289141,"median":-17.666899,"eighty":-13.997737,"marketCap":3772354980},{"date":"2022-07-22","current":-16.540555,"twenty":-19.000023,"median":-17.637365,"eighty":-14.143712,"marketCap":3826711680},{"date":"2022-07-29","current":-15.769476,"twenty":-18.747643,"median":-17.569111,"eighty":-14.282271,"marketCap":3652770240},{"date":"2022-08-05","current":-16.327325,"twenty":-18.677534,"median":-17.396263,"eighty":-14.357524,"marketCap":3772354980},{"date":"2022-08-12","current":-16.540049,"twenty":-18.643914,"median":-17.288694,"eighty":-14.388894,"marketCap":3826711680},{"date":"2022-08-19","current":-16.280106,"twenty":-18.622948,"median":-17.233543,"eighty":-14.502281,"marketCap":3728869620},{"date":"2022-08-26","current":-18.968898,"twenty":-18.789197,"median":-17.288694,"eighty":-14.644506,"marketCap":3815840340},{"date":"2022-09-02","current":-16.867763,"twenty":-18.730307,"median":-17.347726,"eighty":-14.697577,"marketCap":3380986740},{"date":"2022-09-09","current":-16.76889,"twenty":-18.677534,"median":-17.249775,"eighty":-14.757865,"marketCap":3348372720},{"date":"2022-09-16","current":-15.716335,"twenty":-18.64955,"median":-17.115151,"eighty":-14.796788,"marketCap":3109203240},{"date":"2022-09-23","current":-15.015443,"twenty":-18.62618,"median":-16.946014,"eighty":-14.839374,"marketCap":2913519120},{"date":"2022-09-30","current":-15.37826,"twenty":-18.614156,"median":-16.751565,"eighty":-14.921103,"marketCap":2989618500},{"date":"2022-10-07","current":-14.819903,"twenty":-18.606636,"median":-16.630085,"eighty":-14.836542,"marketCap":2880905100},{"date":"2022-10-14","current":-13.000449,"twenty":-18.587919,"median":-16.540555,"eighty":-14.695572,"marketCap":2500408200},{"date":"2022-10-21","current":-13.203919,"twenty":-18.5546,"median":-16.521647,"eighty":-14.34519,"marketCap":2522150880},{"date":"2022-10-28","current":-14.480815,"twenty":-18.46151,"median":-16.451964,"eighty":-14.220761,"marketCap":2761320360},{"date":"2022-11-04","current":-17.728963,"twenty":-18.445575,"median":-16.484507,"eighty":-14.220761,"marketCap":3413600760},{"date":"2022-11-11","current":-16.285217,"twenty":-18.404401,"median":-16.520848,"eighty":-14.319989,"marketCap":3163559940},{"date":"2022-11-18","current":-20.103605,"twenty":-18.5546,"median":-16.540302,"eighty":-14.34519,"marketCap":3891939720},{"date":"2022-11-25","current":-17.886989,"twenty":-18.5546,"median":-16.584302,"eighty":-14.376203,"marketCap":3435343440},{"date":"2022-12-02","current":-19.030264,"twenty":-18.606636,"median":-16.684302,"eighty":-14.417431,"marketCap":3717998280},{"date":"2022-12-09","current":-19.130787,"twenty":-18.629412,"median":-16.76889,"eighty":-14.498534,"marketCap":3772354980},{"date":"2022-12-16","current":-20.667558,"twenty":-18.761338,"median":-16.964223,"eighty":-14.594443,"marketCap":4065881160},{"date":"2022-12-23","current":-24.859641,"twenty":-18.956709,"median":-17.233543,"eighty":-14.695572,"marketCap":4892103000},{"date":"2022-12-30","current":-25.871174,"twenty":-19.083574,"median":-17.249775,"eighty":-14.69858,"marketCap":5153015160},{"date":"2023-01-06","current":-25.12186,"twenty":-19.140053,"median":-17.290439,"eighty":-14.757865,"marketCap":5055173100},{"date":"2023-01-13","current":-24.544401,"twenty":-19.323084,"median":-17.396263,"eighty":-14.796822,"marketCap":5033430420},{"date":"2023-01-20","current":-23.420078,"twenty":-19.652908,"median":-17.543878,"eighty":-14.810698,"marketCap":4761646920},{"date":"2023-01-27","current":-23.468747,"twenty":-19.824386,"median":-17.569111,"eighty":-14.819903,"marketCap":4772518260},{"date":"2023-02-03","current":-24.305158,"twenty":-20.244661,"median":-17.636045,"eighty":-14.865105,"marketCap":4968202380},{"date":"2023-02-10","current":-21.134736,"twenty":-20.667558,"median":-17.653236,"eighty":-14.903098,"marketCap":4294179300},{"date":"2023-02-17","current":-19.716053,"twenty":-20.880127,"median":-17.673991,"eighty":-14.948111,"marketCap":3968039100},{"date":"2023-02-24","current":-17.499248,"twenty":-20.667558,"median":-17.683976,"eighty":-14.962767,"marketCap":3478828800},{"date":"2023-03-03","current":-17.930481,"twenty":-20.549416,"median":-17.681738,"eighty":-14.98647,"marketCap":3587542200},{"date":"2023-03-10","current":-16.312167,"twenty":-16.61243,"median":-16.354707,"eighty":-16.246481,"marketCap":3239659320},{"date":"2023-03-17","current":-15.99321,"twenty":-859.547185,"median":-27.214831,"eighty":-15.236448,"marketCap":3207045300},{"date":"2023-03-24","current":-8.158391,"twenty":-857.733696,"median":-27.194813,"eighty":-15.146534,"marketCap":2957004480},{"date":"2023-03-31","current":-7.55624,"twenty":-856.818296,"median":-27.138398,"eighty":-15.059097,"marketCap":2717835000},{"date":"2023-04-06","current":-7.893805,"twenty":-856.073051,"median":-27.078657,"eighty":-15.049314,"marketCap":2837419740},{"date":"2023-04-14","current":-8.61117,"twenty":-855.930861,"median":-27.005778,"eighty":-15.016535,"marketCap":3098331900},{"date":"2023-04-21","current":-7.829618,"twenty":-853.743672,"median":-26.946633,"eighty":-14.959836,"marketCap":2815677060},{"date":"2023-04-28","current":-7.736069,"twenty":-851.842458,"median":-26.911578,"eighty":-14.890978,"marketCap":2761320360},{"date":"2023-05-05","current":-8.453174,"twenty":-850.368239,"median":-26.887993,"eighty":-14.810698,"marketCap":3022232520},{"date":"2023-05-12","current":-7.654484,"twenty":-844.255875,"median":-26.864581,"eighty":-14.748851,"marketCap":2717835000},{"date":"2023-05-19","current":-7.204671,"twenty":-840.637331,"median":-26.809281,"eighty":-14.567812,"marketCap":2522150880},{"date":"2023-05-25","current":-7.047343,"twenty":-839.945996,"median":-26.786513,"eighty":-14.442753,"marketCap":2456922840},{"date":"2023-06-02","current":-5.913628,"twenty":-835.38621,"median":-26.758553,"eighty":-14.376203,"marketCap":2054683260},{"date":"2023-06-09","current":-5.702832,"twenty":-818.129553,"median":-26.710974,"eighty":-14.315719,"marketCap":1978583880},{"date":"2023-06-16","current":-6.044208,"twenty":-802.117148,"median":-26.699006,"eighty":-14.193526,"marketCap":2086980480},{"date":"2023-06-23","current":-5.845382,"twenty":-785.68443,"median":-26.663692,"eighty":-13.898995,"marketCap":2007320300},{"date":"2023-06-30","current":-5.980535,"twenty":-778.272292,"median":-26.61418,"eighty":-13.87645,"marketCap":2035154520},{"date":"2023-07-07","current":-6.605364,"twenty":-429.563707,"median":-26.606395,"eighty":-13.753995,"marketCap":2243396480},{"date":"2023-07-14","current":-6.997294,"twenty":-301.659425,"median":-26.583832,"eighty":-13.673153,"marketCap":2409856960},{"date":"2023-07-21","current":-6.759426,"twenty":-288.581382,"median":-26.525876,"eighty":-13.629373,"marketCap":2317116240},{"date":"2023-07-28","current":-6.234106,"twenty":-276.345263,"median":-26.501017,"eighty":-13.418778,"marketCap":2134750610},{"date":"2023-08-04","current":-5.879734,"twenty":-267.511133,"median":-26.433729,"eighty":-13.322151,"marketCap":2016749320},{"date":"2023-08-11","current":-5.535688,"twenty":-209.927243,"median":-26.317959,"eighty":-13.137257,"marketCap":1888020640},{"date":"2023-08-18","current":-5.702326,"twenty":-206.412816,"median":-26.285946,"eighty":-13.008751,"marketCap":1930930200},{"date":"2023-08-25","current":-8.437208,"twenty":-153.130438,"median":-26.194028,"eighty":-12.926079,"marketCap":2209842340},{"date":"2023-09-01","current":-8.966812,"twenty":-53.382403,"median":-26.066754,"eighty":-12.827356,"marketCap":2358305400},{"date":"2023-09-08","current":-8.927792,"twenty":-49.491615,"median":-25.991719,"eighty":-12.748779,"marketCap":2320400530},{"date":"2023-09-15","current":-7.693984,"twenty":-47.216764,"median":-25.915129,"eighty":-12.699259,"marketCap":2015229510},{"date":"2023-09-22","current":-7.514168,"twenty":-46.322006,"median":-25.798974,"eighty":-12.601365,"marketCap":1959526400},{"date":"2023-09-29","current":-8.005269,"twenty":-45.602151,"median":-25.742295,"eighty":-12.513573,"marketCap":2091174700},{"date":"2023-10-06","current":-7.794811,"twenty":-44.867875,"median":-25.623114,"eighty":-12.464811,"marketCap":2035223040},{"date":"2023-10-13","current":-7.593854,"twenty":-44.174678,"median":-25.459845,"eighty":-12.377739,"marketCap":1979791440},{"date":"2023-10-20","current":-7.173699,"twenty":-43.742069,"median":-24.944313,"eighty":-12.316404,"marketCap":1867371240},{"date":"2023-10-27","current":-7.332259,"twenty":-43.600883,"median":-24.544401,"eighty":-12.227731,"marketCap":1907826880},{"date":"2023-11-03","current":-7.467694,"twenty":-43.226685,"median":-24.305158,"eighty":-11.9436,"marketCap":1948225750},{"date":"2023-11-10","current":-7.539507,"twenty":-42.611945,"median":-23.686985,"eighty":-11.104028,"marketCap":1966549970},{"date":"2023-11-17","current":-7.348049,"twenty":-42.179625,"median":-23.417707,"eighty":-10.369722,"marketCap":1933897040},{"date":"2023-11-24","current":-7.63362,"twenty":-41.40647,"median":-22.798937,"eighty":-10.175003,"marketCap":2025594830},{"date":"2023-12-01","current":-7.277958,"twenty":-40.622269,"median":-22.111475,"eighty":-10.082303,"marketCap":1939227350},{"date":"2023-12-08","current":-6.705384,"twenty":-39.890302,"median":-21.490504,"eighty":-9.976804,"marketCap":1779442700},{"date":"2023-12-15","current":-6.541665,"twenty":-39.34123,"median":-20.977411,"eighty":-9.850148,"marketCap":1746020070},{"date":"2023-12-22","current":-6.098485,"twenty":-38.040839,"median":-20.549416,"eighty":-9.736195,"marketCap":1626644760},{"date":"2023-12-29","current":-5.677286,"twenty":-37.684082,"median":-20.244661,"eighty":-9.647662,"marketCap":1522372660},{"date":"2024-01-05","current":-5.003084,"twenty":-37.205408,"median":-19.863698,"eighty":-9.579458,"marketCap":1332122880},{"date":"2024-01-12","current":-5.31345,"twenty":-36.743617,"median":-19.590787,"eighty":-9.495308,"marketCap":1415514140},{"date":"2024-01-19","current":-5.871801,"twenty":-36.390552,"median":-19.317006,"eighty":-9.4536,"marketCap":1562111600},{"date":"2024-01-26","current":-6.568447,"twenty":-36.077009,"median":-19.153952,"eighty":-9.378434,"marketCap":1740643600},{"date":"2024-02-02","current":-6.549533,"twenty":-35.939845,"median":-19.030264,"eighty":-9.332778,"marketCap":1733418600},{"date":"2024-02-09","current":-6.6813,"twenty":-35.587972,"median":-18.817772,"eighty":-9.258152,"marketCap":1777000750},{"date":"2024-02-16","current":-7.015472,"twenty":-35.201054,"median":-18.681712,"eighty":-9.243388,"marketCap":1866282560},{"date":"2024-02-23","current":-6.965496,"twenty":-34.904271,"median":-18.584004,"eighty":-9.15982,"marketCap":1843219560},{"date":"2024-03-01","current":-6.578674,"twenty":-34.762406,"median":-18.393775,"eighty":-9.048962,"marketCap":1741943760},{"date":"2024-03-08","current":-6.116976,"twenty":-34.291324,"median":-18.358603,"eighty":-8.989107,"marketCap":1620412800},{"date":"2024-03-15","current":-6.31372,"twenty":-34.169695,"median":-18.286774,"eighty":-8.966068,"marketCap":1671050700},{"date":"2024-03-22","current":-6.0897,"twenty":-34.007358,"median":-18.165862,"eighty":-8.908417,"marketCap":1610285220},{"date":"2024-03-28","current":-9.241453,"twenty":-33.918806,"median":-18.128877,"eighty":-8.893205,"marketCap":1448243940},{"date":"2024-04-05","current":-8.536193,"twenty":-33.589784,"median":-18.065512,"eighty":-8.838523,"marketCap":1336840560},{"date":"2024-04-12","current":-8.272823,"twenty":-33.35649,"median":-17.939408,"eighty":-8.727145,"marketCap":1296330240},{"date":"2024-04-19","current":-8.279892,"twenty":-33.174366,"median":-17.853668,"eighty":-8.605272,"marketCap":1296330240},{"date":"2024-04-26","current":-8.678713,"twenty":-33.059884,"median":-17.759229,"eighty":-8.524743,"marketCap":1357095720},{"date":"2024-05-03","current":-9.203206,"twenty":-32.801614,"median":-17.687796,"eighty":-8.477563,"marketCap":1438116360},{"date":"2024-05-10","current":-9.181408,"twenty":-32.632919,"median":-17.661614,"eighty":-8.477563,"marketCap":1438116360},{"date":"2024-05-17","current":-8.741635,"twenty":-32.551122,"median":-17.623136,"eighty":-8.477563,"marketCap":1367223300},{"date":"2024-05-24","current":-8.177535,"twenty":-32.325579,"median":-17.539325,"eighty":-8.449981,"marketCap":1276075080},{"date":"2024-05-31","current":-7.845046,"twenty":-32.033995,"median":-17.347726,"eighty":-8.385666,"marketCap":1225437180},{"date":"2024-06-07","current":-7.400377,"twenty":-31.809988,"median":-17.233543,"eighty":-8.298959,"marketCap":1154544120},{"date":"2024-06-14","current":-6.887364,"twenty":-31.578107,"median":-16.935206,"eighty":-8.273349,"marketCap":1073523480},{"date":"2024-06-21","current":-5.860029,"twenty":-31.347447,"median":-16.734241,"eighty":-8.218166,"marketCap":911482200},{"date":"2024-06-28","current":-5.211077,"twenty":-31.228256,"median":-16.576517,"eighty":-8.179208,"marketCap":810206400},{"date":"2024-07-05","current":-6.059193,"twenty":-31.009798,"median":-16.520848,"eighty":-8.127037,"marketCap":941864940},{"date":"2024-07-12","current":-6.115326,"twenty":-30.76933,"median":-16.436478,"eighty":-8.062904,"marketCap":951986880},{"date":"2024-07-19","current":-7.004141,"twenty":-30.557099,"median":-16.340035,"eighty":-8.028781,"marketCap":1090371240},{"date":"2024-07-26","current":-7.669327,"twenty":-30.166665,"median":-16.305518,"eighty":-7.995559,"marketCap":1198359750},{"date":"2024-08-02","current":-6.796557,"twenty":-29.911296,"median":-16.197141,"eighty":-7.891041,"marketCap":1061367400},{"date":"2024-08-09","current":-5.605068,"twenty":-29.68082,"median":-16.109649,"eighty":-7.860985,"marketCap":881135200},{"date":"2024-08-16","current":-5.284545,"twenty":-29.399025,"median":-16.004915,"eighty":-7.841452,"marketCap":831070700},{"date":"2024-08-23","current":-4.945296,"twenty":-29.313204,"median":-15.849402,"eighty":-7.79201,"marketCap":781006200},{"date":"2024-08-30","current":-5.353167,"twenty":-29.110493,"median":-15.769476,"eighty":-7.728882,"marketCap":851096500},{"date":"2024-09-06","current":-3.418622,"twenty":-28.890701,"median":-15.662682,"eighty":-7.666358,"marketCap":971251300},{"date":"2024-09-13","current":-3.060869,"twenty":-28.749884,"median":-15.561249,"eighty":-7.617596,"marketCap":867335190},{"date":"2024-09-20","current":-3.483773,"twenty":-28.561104,"median":-15.420271,"eighty":-7.598347,"marketCap":993090000},{"date":"2024-09-27","current":-3.760093,"twenty":-28.333146,"median":-15.365842,"eighty":-7.561653,"marketCap":1078304300},{"date":"2024-10-04","current":-4.747552,"twenty":-28.250282,"median":-15.319205,"eighty":-7.535461,"marketCap":1355299900},{"date":"2024-10-10","current":-4.708735,"twenty":-28.130154,"median":-15.28172,"eighty":-7.522101,"marketCap":1335514500},{"date":"2024-10-18","current":-4.628229,"twenty":-28.007466,"median":-15.211834,"eighty":-7.460943,"marketCap":1305836400},{"date":"2024-10-25","current":-4.787628,"twenty":-27.863809,"median":-15.071389,"eighty":-7.420411,"marketCap":1350724680},{"date":"2024-11-01","current":-4.888412,"twenty":-27.732043,"median":-15.043947,"eighty":-7.390073,"marketCap":1380088260},{"date":"2024-11-08","current":-5.393498,"twenty":-27.592224,"median":-14.969216,"eighty":-7.334181,"marketCap":1515776000},{"date":"2024-11-15","current":-5.694569,"twenty":-27.430791,"median":-14.889359,"eighty":-7.267767,"marketCap":1583441460},{"date":"2024-11-22","current":-6.224792,"twenty":-27.252497,"median":-14.784149,"eighty":-7.20416,"marketCap":1730056410},{"date":"2024-11-29","current":-5.401652,"twenty":-27.149392,"median":-14.63199,"eighty":-7.145452,"marketCap":1500274450},{"date":"2024-12-06","current":-6.462356,"twenty":-26.958966,"median":-14.415446,"eighty":-7.084264,"marketCap":1790650150},{"date":"2024-12-13","current":-7.525158,"twenty":-26.898699,"median":-14.328346,"eighty":-7.042598,"marketCap":2081025850},{"date":"2024-12-20","current":-9.773511,"twenty":-26.831826,"median":-14.194883,"eighty":-7.042598,"marketCap":2690814820},{"date":"2024-12-27","current":-10.308856,"twenty":-26.785545,"median":-13.98128,"eighty":-7.042598,"marketCap":2836002670},{"date":"2025-01-03","current":-11.036911,"twenty":-26.724476,"median":-13.876142,"eighty":-7.042598,"marketCap":3039265660},{"date":"2025-01-10","current":-10.090962,"twenty":-26.659448,"median":-13.738689,"eighty":-7.042598,"marketCap":2768248340},{"date":"2025-01-17","current":-13.505837,"twenty":-26.604626,"median":-13.644863,"eighty":-7.042598,"marketCap":3708038950},{"date":"2025-01-24","current":-14.258417,"twenty":-26.513964,"median":-13.644863,"eighty":-7.042598,"marketCap":3939189430},{"date":"2025-01-28","current":-14.045364,"twenty":-26.50266,"median":-13.646172,"eighty":-7.044971,"marketCap":3900664350},{"date":"2025-02-07","current":-14.613563,"twenty":-26.385453,"median":-13.643555,"eighty":-7.040226,"marketCap":4035502130},{"date":"2025-02-14","current":-14.027409,"twenty":-26.305488,"median":-13.643555,"eighty":-7.040226,"marketCap":3871770540},{"date":"2025-02-21","current":-20.966333,"twenty":-26.268748,"median":-13.643555,"eighty":-7.040226,"marketCap":5807655810},{"date":"2025-02-28","current":-23.024105,"twenty":-26.124527,"median":-13.643555,"eighty":-7.040226,"marketCap":6356638200},{"date":"2025-03-07","current":-23.948261,"twenty":-26.021583,"median":-13.637196,"eighty":-7.037853,"marketCap":6638331300},{"date":"2025-03-14","current":-27.478442,"twenty":-25.994745,"median":-13.637196,"eighty":-7.037853,"marketCap":7619649840},{"date":"2025-03-21","current":-28.63462,"twenty":-25.994745,"median":-13.637196,"eighty":-7.037853,"marketCap":7937135250},{"date":"2025-03-28","current":-22.254415,"twenty":-25.981622,"median":-13.637196,"eighty":-7.037853,"marketCap":7167473650},{"date":"2025-04-03","current":-19.455031,"twenty":-25.920491,"median":-13.637196,"eighty":-7.037853,"marketCap":6253500500}],"updateTime":1743992251875}}}